Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Sutro Biopharma Announces $85.4m Series E Round
Venture Capital

Sutro Biopharma Announces $85.4m Series E Round

by prnewswire.com posted 4months ago 46 views
SOUTH SAN FRANCISCO, Calif., July 26, 2018 /PRNewswire/ -- Sutro Biopharma, Inc., has secured $85.4 million in Series E financing to advance its wholly-owned pipeline of novel cancer therapeutics, including two internally-developed antibody drug conjugates, or ADCs, known as STRO-001, now ...

In this article